Stephen Liu, Chief of the Division of Hematology and Oncology, and Associate Professor at Georgetown Lombardi Comprehensive Cancer Center, shared on X:
“Summary of sunvozertinib for EGFR exon 20 NSCLC – now hopefully will gain access after AstraZeneca has acquired global rights. Looking forward to having this as an option soon…
Other articles featuring Stephen V Liu on OncoDaily.